NCT00005879View on ClinicalTrials.gov

LY353381 in Preventing Breast Cancer in Women With Hyperplasia

PHASE2CompletedINTERVENTIONAL
Enrollment

199

Participants

Timeline

Start Date

August 31, 2000

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Breast Cancer
Interventions
DRUG

arzoxifene

one tablet daily

DRUG

Placebo

matched tablet dialy

Trial Locations (2)

75246

U.S. Oncology Research, Inc., Dallas

66160-7820

University of Kansas Medical Center, Kansas City

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

University of Kansas Medical Center

OTHER

NCT00005879 - LY353381 in Preventing Breast Cancer in Women With Hyperplasia | Biotech Hunter | Biotech Hunter